Short Interest in Silo Pharma, Inc. (NASDAQ:SILO) Drops By 16.1%

Silo Pharma, Inc. (NASDAQ:SILO) was the target of a large decline in short interest in February. As of February 28th, there was short interest totalling 130,600 shares, a decline of 16.1% from the February 13th total of 155,700 shares. Based on an average daily trading volume, of 2,910,000 shares, the short-interest ratio is presently 0.0 days. Approximately 3.0% of the shares of the stock are short sold.

Silo Pharma Stock Down 0.7 %

NASDAQ SILO opened at $1.37 on Wednesday. Silo Pharma has a 52-week low of $0.77 and a 52-week high of $4.50. The company has a fifty day moving average of $1.57 and a 200-day moving average of $1.23.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.